salvinorin a has been researched along with nalbuphine in 1 studies
| Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (nalbuphine) | Trials (nalbuphine) | Recent Studies (post-2010) (nalbuphine) |
|---|---|---|---|---|---|
| 247 | 7 | 128 | 793 | 269 | 185 |
| Protein | Taxonomy | salvinorin a (IC50) | nalbuphine (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 0.0578 | |
| Delta-type opioid receptor | Homo sapiens (human) | 1.1195 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 0.097 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Béguin, C; Bohn, LM; Carlezon, WA; Cohen, BM; Groer, CE; Liu-Chen, LY; Potuzak, J; Streicher, JM; Xu, W | 1 |
1 other study(ies) available for salvinorin a and nalbuphine
| Article | Year |
|---|---|
Differential signaling properties at the kappa opioid receptor of 12-epi-salvinorin A and its analogues.
Topics: Cell Line, Tumor; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Humans; Molecular Conformation; Receptors, Opioid, kappa; Signal Transduction; Structure-Activity Relationship | 2012 |